FIELD: medicine. SUBSTANCE: method involves administering mexidol for treating opium narcomania. Mexidol weakens the process of opiate addiction formation causing curative influence on abstinence syndrome manifestations. EFFECT: enhanced effectiveness of treatment. 3 cl, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR TERMINATION OF OPIATE ABSTINENT SYNDROME MANIFESTATIONS | 2007 |
|
RU2323725C1 |
| DRUG SHOWING ANXIOLYTIC, ANTIALCOHOLIC AND CEREBROPROTECTIVE EFFECTS | 1999 |
|
RU2145855C1 |
| AGENT FOR DRUG ADDICT TREATMENT | 2000 |
|
RU2162330C1 |
| AGENT FOR ARRESTING AN ABSTINENT SYNDROME AT OPIOMANIA | 1996 |
|
RU2116084C1 |
| AGENT FOR ABSTINENT SYNDROME ARRESTING AT OPIOMANIA | 1993 |
|
RU2083204C1 |
| MEANS FOR OPIOID ABSTINENCE SYNDROME ARRESTING | 2017 |
|
RU2643588C1 |
| AGENT FOR TREATMENT OF COMPULSIVE INCLINATION TO NARCOTIC-OPIATE | 1997 |
|
RU2152799C1 |
| IMMUNOGEN FOR TREATING AND PREVENTING OPIATE ADDICTION | 2013 |
|
RU2548802C1 |
| 2-ETHYL-6-METHYL-3-OXYPYRODINE SALTS WITH ORGANIC CARBOXYLIC ACIDS POSSESSING ANXIOLYTIC, ANTIDEPRESSIVE, ANTIHYPOXIC, ANTI-AMNESTIC AND ANTI-OXIDATIVE ACTIVITY AND METHOD FOR THEIR PREPARING | 2002 |
|
RU2284993C2 |
| METHOD OF OPIUM NARCOMANIA TREATMENT | 1999 |
|
RU2192275C2 |
